SciSparc Ltd. (SPRC) stock
SPRCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.33−0.00 (-0.30%)
Close on Nov 17, 2026Market cap $120.49KP/E 0.0Yield –
SciSparc operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was -$8.37M. The highest annual figure on record is $2.56M in fiscal 2015.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.37M | – |
| FY2024 | Dec 31, 2024 | -$7.32M | – |
| FY2023 | Dec 31, 2023 | -$6.82M | – |
| FY2022 | Dec 31, 2022 | -$8.29M | – |
| FY2021 | Dec 31, 2021 | -$5.77M | – |
| FY2020 | Dec 31, 2020 | -$3.29M | – |
| FY2019 | Dec 31, 2019 | -$4.11M | – |
| FY2018 | Dec 31, 2018 | -$7.24M | – |
| FY2017 | Dec 31, 2017 | -$5.75M | – |
| FY2016 | Dec 31, 2016 | -$2.00M | -178.0% |
| FY2015 | Dec 31, 2015 | $2.56M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2018 | Jun 30, 2018 | -$1.65M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.43M | – |
See a number that looks wrong?